China: Pharma Investigations Show New Trends In Commercial Bribery Enforcement

Last Updated: 3 July 2014
Article by Chris Chen, Richard Ma and Xing Wan

A number of recent commercial bribery cases concerning multinational pharmaceutical companies have drawn extensive attention. On 14 May 2014, the Chinese police published the results of their year-long investigation into commercial bribery allegations against GlaxoSmithKline, and reportedly have transferred the case to the prosecutor who will bring a criminal case against the company and certain individuals.
In related developments, the Hangzhou office of Swiss pharmaceutical company, Roche, was subject to an unannounced on-site inspection by the local AIC on 21 May 2014, and Eli Lilly, AstraZeneca and Novo Nordisk were named in a Hangzhou Health Bureau internal document for suspicion of commercial bribery. Taken together with the country's recent investigation into domestic pharmaceutical companies such as Sinopharm and Sanjing Pharmaceutical Co., Ltd., these cases show that the government is engaged in a sustained anti-commercial bribery drive focusing on the medical and pharmaceutical industry.

New Trends

A close look at key aspects of the current anti-bribery drive shows that this round of investigations exhibits characteristics distinct from previous anti-bribery campaigns, and its influence extends beyond the medical and pharmaceutical industry itself. We identify the key characteristics of the current anti-bribery drive below.

Shift of Focus from Bribe Receivers to Bribe Givers

In 2006, the Chinese government organized a joint action of some 20 ministries and commissions including the Supreme People's Court, the Ministry of Public Security and the Ministry of Health to specifically target bribe-taking hospitals and medical institutions.  Now, after years of anti-bribery practice, the Chinese government has realized the importance of punishing both the giving and receiving of commercial bribes, and is instead, in the current anti-bribery drive, focusing on investigating pharmaceutical companies that are typically in the position of offering bribes.

Increasing Regulatory Scrutiny of Multinationals

In recent years, regulation of, and law enforcement against, multinational companies by the Chinese government have become increasingly intensified. In addition to the companies caught up in this latest round of investigations, many other well-known multinational companies have been investigated in China in recent years on suspicion of commercial bribery, including Morgan Stanley, IBM, Lucent, Wal-Mart, DPC and Siemens.
In addition, in the GSK case, the Chinese government brought prosecution cases against GlaxoSmithKline China, its pharmaceutical subsidiaries and senior officers overseeing the company's China operations. The accused individuals include both Chinese nationals as well as foreign senior managers who voluntarily returned to China to assist with the investigation, which has been rare in previous cases. Video of the interview with a GlaxoSmithKline senior manager who admitted his guilt was broadcast on CCTV. This unusually publicized process demonstrates that the Chinese government is paying particular attention to multinational companies and is increasing scrutiny of multinationals in anti-commercial bribery actions.

Focus on Pricing and Other Business Fundamentals

During the current anti-bribery drive, the Chinese government is also focusing on what it sees as root causes of commercial bribery such as product pricing and "transfer pricing". In the GSK case, some reports have alleged that the prices of GlaxoSmithKline drugs in China were substantially higher than prices for the same drugs in other countries, and that GlaxoSmithKline's commercial bribery activities in China were made possible by the enormous profits generated through transfer pricing. According to these reports, GlaxoSmithKline allegedly increased the price of pharmaceutical products imported to China by way of internal transfer pricing, which elevated the apparent cost of sales in China without increasing the actual cost to the company. In 2013, in an inquiry into pharmaceutical product prices, the National Development and Reform Commission was reported to have made special on-site visits to investigate production costs and pricing mechanisms of dozens of domestic and foreign pharmaceutical companies. Further inquiries are expected to extend to fundamental business issues, such as product pricing, in connection with the commercial bribery investigations.

Our Advice

This latest round of anti-commercial bribery investigations shows that, as a result of increasing competition in the Chinese market, multinationals are facing a more strict and complicated regulatory and compliance environment in China, and must strive to comply with the regulatory requirements while remaining competitive in the market. Drawing on our extensive experience advising multinational companies operating in China, we believe that the following guidelines are the keys to establishing and operating an effective compliance system in China.

Establish China-specific Compliance Systems

The "localization" of multinationals' global compliance mechanisms is critical. The first and foremost step in localization is identifying targeted "red flags" that signal the most risky circumstances and require heightened attention. Common red flags for Chinese companies include giving excessive gifts, having luxury business meals/entertainment, hosting and sponsoring various types of expensive conferences, retaining advisors and agents designated by interested parties, or hiring employees recommended by interested parties, etc. In response to these red flags, multinationals may formulate tailor-made reporting, recording, approval, and reimbursement procedures to minimize the risk of non-compliance.

Strengthen the Training and Education of Employees

A robust compliance system depends on the understanding and implementation of employees. Therefore, it is essential to strengthen training and education programs to ensure that employees fully understand compliance requirements and are held responsible for effective execution. In addition, in China's pro-employee legal environment, an employer could easily find itself in a disadvantageous position if a dispute arises between the employer and its employees due to misunderstandings regarding the company's compliance requirements. An effective safeguard in this situation is to have a regular, thorough and vigorous compliance training program in place that defuses confusion and misunderstanding.

Closely Monitor Any Enforcement Trends

In our experience, enforcement actions by the Chinese government tend to come in waves, and government actions in a given period may share similar characteristics and exhibit certain trends in terms of enforcement focus and policy considerations. We believe it is important for multinational companies to closely monitor any enforcement trends and therefore benefit from the timely analysis of enforcement actions, recognition of the specific characteristics, and prompt adoption of preemptive measures to address any potential issues.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions